tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TECX Stock Latest News

Tectonic Therapeutic: Buy Rating on De‑Risked TX‑45 Phase 2 Program, Emerging TX2100 Pipeline, and Sufficient Cash Runway to 2026 Data Catalysts
RatingsTectonic Therapeutic: Buy Rating on De‑Risked TX‑45 Phase 2 Program, Emerging TX2100 Pipeline, and Sufficient Cash Runway to 2026 Data Catalysts
20d ago
TECX
Tectonic Therapeutic Announces Leadership Transition and New Chair
PremiumCompany Announcements
Tectonic Therapeutic Announces Leadership Transition and New Chair
23d ago
8K
TECX
Tectonic Therapeutic chair Terry McGuire to retire, Francois Nader to succeed
PremiumThe Fly
Tectonic Therapeutic chair Terry McGuire to retire, Francois Nader to succeed
24d ago
TECX
Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts
PremiumRatings
Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts
1M ago
TECX
Tectonic Therapeutic price target lowered to $60 from $64 at Truist
PremiumThe Fly
Tectonic Therapeutic price target lowered to $60 from $64 at Truist
2M ago
TECX
Positive Outlook for Tectonic Therapeutic: Buy Rating Supported by Strategic Focus and Promising Trial Results
PremiumRatingsPositive Outlook for Tectonic Therapeutic: Buy Rating Supported by Strategic Focus and Promising Trial Results
4M ago
TECX
Promising Outlook for Tectonic Therapeutic: Buy Rating Affirmed Amid Strong Financials and Progress in TX45 Trial
Premium
Ratings
Promising Outlook for Tectonic Therapeutic: Buy Rating Affirmed Amid Strong Financials and Progress in TX45 Trial
4M ago
TECX
Tectonic Therapeutic Reports Q3 2025 Financial Results
Premium
Company Announcements
Tectonic Therapeutic Reports Q3 2025 Financial Results
4M ago
TECX
Tectonic Therapeutic reports Q3 EPS ($1.02), consensus ($1.05)
PremiumThe Fly
Tectonic Therapeutic reports Q3 EPS ($1.02), consensus ($1.05)
4M ago
TECX
Tectonic Therapeutic Reports Positive Phase 1b Trial Results
PremiumCompany Announcements
Tectonic Therapeutic Reports Positive Phase 1b Trial Results
5M ago
8K
TECX
Promising Phase 1b Trial Results and Market Expansion Justify Buy Rating for Tectonic Therapeutic
PremiumRatings
Promising Phase 1b Trial Results and Market Expansion Justify Buy Rating for Tectonic Therapeutic
5M ago
TECX
Tectonic Therapeutic Inc trading resumes
PremiumThe Fly
Tectonic Therapeutic Inc trading resumes
5M ago
TECX
Tectonic Therapeutic Inc trading halted, news pending
PremiumThe FlyTectonic Therapeutic Inc trading halted, news pending
5M ago
TECX
Tectonic Therapeutic’s Promising Phase 2 Study on TX000045 for Pulmonary Hypertension
Premium
Company Announcements
Tectonic Therapeutic’s Promising Phase 2 Study on TX000045 for Pulmonary Hypertension
5M ago
TECX
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
6M ago
CGEM
TECX
Optimistic Outlook on Tectonic Therapeutic: Strategic Trial Design and Upcoming Catalysts
PremiumRatings
Optimistic Outlook on Tectonic Therapeutic: Strategic Trial Design and Upcoming Catalysts
7M ago
TECX
Tectonic Therapeutic initiated with an Outperform at Oppenheimer
PremiumThe Fly
Tectonic Therapeutic initiated with an Outperform at Oppenheimer
7M ago
TECX
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback
PremiumRatings
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback
7M ago
TECX
Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist
PremiumThe Fly
Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist
7M ago
LLY
TECX
Tectonic Therapeutic’s Strategic Expansion and Financial Stability Justify Buy Rating
PremiumRatingsTectonic Therapeutic’s Strategic Expansion and Financial Stability Justify Buy Rating
7M ago
TECX
Tectonic Therapeutic’s Strategic Advancements and Promising Pipeline Drive Buy Rating
Premium
Ratings
Tectonic Therapeutic’s Strategic Advancements and Promising Pipeline Drive Buy Rating
7M ago
TECX
Promising Outlook for Tectonic Therapeutic: Strategic Differentiation and Market Opportunities
Premium
Ratings
Promising Outlook for Tectonic Therapeutic: Strategic Differentiation and Market Opportunities
7M ago
TECX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >